Dr. Randall on Emerging Treatment Strategies in Cervical Cancer

Video

Leslie M. Randall, MD, associate professor, Division of Gynecologic Oncology, UC Irvine Health, discusses emerging treatment strategies in the treatment of patients with cervical cancer.

Leslie M. Randall, MD, associate professor, Division of Gynecologic Oncology, UC Irvine Health, discusses emerging treatment strategies for patients with cervical cancer.

The current management of patients with locally advanced cervical cancer is chemoradiation—this has been the standard of care for 20 years. Ongoing research is looking to improve this paradigm by bringing immunotherapy into the mix, Randall says.

In the metastatic setting, immunotherapy is being studied in several different ways. One approach is looking at cellular-based therapy through tumor infiltrating lymphocytes. Noncellular therapies on the rise include PD-1/PD-L1 and CTLA-4 inhibitors, as well as antibody-drug conjugates. Moreover, PARP inhibitors, which have transformed the ovarian cancer space, are also being studied in combination with immunotherapy and PIK3CA inhibition in cervical cancer, Randall says.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD